Literature DB >> 27875475

Scar-based catheter ablation for persistent atrial fibrillation.

Pablo B Nery1, Rebecca Thornhill, Girish M Nair, Elena Pena, Calum J Redpath.   

Abstract

PURPOSE OF REVIEW: Percutaneous catheter ablation can be an effective treatment for paroxysmal atrial fibrillation. However, catheter ablation for the treatment of persistent atrial fibrillation or long-standing persistent atrial fibrillation is associated with success rates of 45-50% at 1 year. To address the challenge of ablating patients with persistent atrial fibrillation, several approaches have been proposed. Atrial scar-based catheter ablation is a promising strategy for ablation of persistent atrial fibrillation. RECENT
FINDINGS: In this review, we outline the role of atrial scar/fibrosis in the pathophysiology of atrial fibrillation and how this encouraged clinical studies assessing the atrial substrate using scar-based mapping. We highlight current approaches to voltage mapping of atrial scar in patients with atrial fibrillation. The characteristics, techniques, and outcomes of recently published studies evaluating scar-based catheter ablation strategies for the treatment of atrial fibrillation are discussed. Finally, we explore the role of noninvasive tools such as delayed enhancement MRI to assess the atrial fibrillation substrate.
SUMMARY: In summary, the optimal catheter ablation strategy for persistent atrial fibrillation remains unknown. Current data highlight the need for a better understanding of the substrate and mechanisms of arrhythmia maintenance in this population. Atrial scar-based catheter ablation has recently emerged as a promising strategy for ablation of atrial fibrillation. However, the available data have limitations that preclude definitive conclusions regarding the utility of this strategy. Further research is needed to assess the role of scar-based ablation for persistent atrial fibrillation.

Entities:  

Mesh:

Year:  2017        PMID: 27875475     DOI: 10.1097/HCO.0000000000000349

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  4 in total

Review 1.  Ablation of long-standing persistent atrial fibrillation.

Authors:  Behram P Mody; Anoshia Raza; Jason Jacobson; Sei Iwai; Daniel Frenkel; Rhadames Rojas; Wilbert S Aronow
Journal:  Ann Transl Med       Date:  2017-08

2.  E/E' Is a New Independent Predictor of Recovered Ejection Fraction in Patients With Systolic Heart Failure Undergoing Ablation for Atrial Fibrillation.

Authors:  Minghui Yang; Rongfeng Zhang; Huamin Tang; Guocao Li; Xumin Guan; Yiheng Yang; Yuanjun Sun; Xianjie Xiao; Xiaohong Yu; Xiaomeng Yin; Yingxue Dong; Lianjun Gao; Yunlong Xia; Yanzong Yang
Journal:  Front Cardiovasc Med       Date:  2022-01-13

3.  Effectiveness of the Early Staged Hybrid Approach for Treatment of Symptomatic Atrial Fibrillation: the Electrophysiology Study Could Be Deferred?

Authors:  Ju Youn Kim; Dong Seop Jeong; Hee-Jin Kwon; Seung-Jung Park; Kyoung-Min Park; June Soo Kim; Young Keun On
Journal:  J Korean Med Sci       Date:  2021-11-08       Impact factor: 2.153

4.  Development of a pro-arrhythmic ex vivo intact human and porcine model: cardiac electrophysiological changes associated with cellular uncoupling.

Authors:  Joseph Brook; Min-Young Kim; Simos Koutsoftidis; David Pitcher; Danya Agha-Jaffar; Annam Sufi; Catherine Jenkins; Konstantinos Tzortzis; Suofeiya Ma; Richard J Jabbour; Charles Houston; Balvinder S Handa; Xinyang Li; Ji-Jian Chow; Anand Jothidasan; Poppy Bristow; Justin Perkins; Sian Harding; Anil A Bharath; Fu Siong Ng; Nicholas S Peters; Chris D Cantwell; Rasheda A Chowdhury
Journal:  Pflugers Arch       Date:  2020-09-01       Impact factor: 3.657

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.